You are here

Status Report from SPAUD Part 3

Part 3: Current Perspectives on Skin and Soft Tissue Infections with Emphasis on Methicillin-resistant Staphylococcus aureus, Commonly Encountered Scenarios when Antibiotic Use May Not Be Needed, and Concluding Remarks on Rational Use of Antibiotics in Dermatology


Abstract

Status Report from SPAUD Part 3
Click here to download the full article.
In this third article of the three-part series, management of skin and soft tissue infections is reviewed with emphasis on new information on methicillin-resistant Staphylococcus aureus. Due to changes in the evolution of methicillin-resistant Staphylococcus aureus clones, previous distinctions between healthcare-acquired methicillin-resistant Staphylococcus aureus and community-acquired methicillin-resistant Staphylococcus aureus are currently much less clinically relevant. Many nosocomial cases of methicillin-resistant Staphylococcus aureus infection are now caused by community-acquired methicillin-resistant Staphylococcus aureus, with changing patterns of antibiotic susceptibility and resistance. Also reviewed are clinical scenarios where antibiotics may not be needed and suggestions for optimal use of antibiotic therapy for dermatologic conditions, including recommendations on perioperative antibiotic use. (J Clin Aesthet Dermatol. 2016;9(6):17–24.)

aJames Q. Del Rosso, DO; bTed Rosen, MD; cDiane Thiboutot, MD; dGuy F. Webster, MD; eRichard L. Gallo, MD, PhD; fJames J. Leyden, MD; gClay Walker, PhD; hGeorge Zhanel, PhD; iLawrence Eichenfield, MD aDermatology Adjunct Faculty, Touro University Nevada, Henderson, Nevada bDepartment of Dermatology, Baylor College of Medicine, Houston, Texas cDepartment of Dermatology, Penn State University, Hershey, Pennsylvania dDepartment of Dermatology, Jefferson Medical College, Philadelphia, Pennsylvania eDepartment of Dermatology, University of California San Diego, San Diego, California fDepartment of Dermatology, University of Pennsylvania, Philadelphia, Pennsylvania gUniversity of Florida College of Dentistry, Gainesville, Florida hDepartment of Medical Microbiology and Infectious Diseases, University of Manitoba, Winnipeg, Canada iDepartment of Dermatology (Pediatrics), University of California San Diego, San Diego, California

Click here to read more: http://www.jcadonline.com/status-report-from-the-scientific-panel-on-antibiotic-use-in-dermatology-of-the-american-acne-and-rosacea-society-part-2-perspectives-on-antibiotic-use-and-the-microbiome-and-review-of-microbiologic/

Click here to download the full article.


Scientific Panel on Antibiotic Use in Dermatology - Status Report

Scientific Panel on Antibiotic Use in Dermatology Meeting Info

Part 1: Antibiotic Prescribing Patterns, Sources of Antibiotic Exposure, Antibiotic Consumption and Emergence of Antibiotic Resistance, Impact of Alterations in Antibiotic Prescribing, and Clinical Sequelae of Antibiotic Use

Part 2: Perspectives on Antibiotic Use and the Microbiome and Review of Microbiologic Effects of Selected Specific Therapeutic Agents Commonly Used by Dermatologists

Part 3: Current Perspectives on Skin and Soft Tissue Infections with Emphasis on Methicillin-resistant Staphylococcus aureus, Commonly Encountered Scenarios when Antibiotic Use May Not Be Needed, and Concluding Remarks on Rational Use of Antibiotics in Dermatology